The Best Dividend Stocks for Retirement Portfolios in 2026 [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Johnson & Johnson raised its dividend 4.8% and grew Q3 revenue 6.8% to $24B with 91% net income jump. AbbVie delivers 2.93% yield with 53-year dividend streak despite accounting distortions from Allergan acquisition debt. A recent study identified one single habit that doubled Americans' retirement savings and moved retirement from dream, to reality. Read more here Retirement portfolios need growing income that outpaces inflation and safety that lets you sleep at night. The best retirement dividend stocks build reliable income streams that compound for decades. These companies raise dividends through recessions, market crashes, and business disruptions. We ranked them by dividend growth consistency, payout sustainability, and business resilience heading into 2026. AbbVie NASDAQ:ABBV ) delivers a 2.93% yield with a 53-year dividend growth streak. The company announced a 5.5% dividend increase despite a trailing P/E of 169x and negative book value of $1.50 per share. The Al
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Bank of America Corporation from $204.00 to $220.00. They now have a "neutral" rating on the stock.MarketBeat
- Johnson & Johnson (NYSE:JNJ) had its price target raised by analysts at Wells Fargo & Company from $212.00 to $230.00. They now have an "overweight" rating on the stock.MarketBeat
- U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care* [Yahoo! Finance]Yahoo! Finance
- U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*PR Newswire
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website